Literature DB >> 3343515

Hazards of the limiting-dilution method of cloning hybridomas.

P A Underwood1, P A Bean.   

Abstract

Three hybridoma clones, which were shown to change the characteristics of their antibody specificities when grown under different culturing conditions, are described in detail. This phenomenon was shown to be due to the persistence of mixed clones, even under conditions where standard statistical treatment indicated a high probability of monoclonality. Such mixed clones persisted, sometimes undetected, through repeated cycles of re-cloning. It was shown that the assumption that every viable clone has the same random chance of monoclonality, is invalid, and can lead to misleadingly high estimates for the probability of monoclonality. Verification of seeding of individual wells with single cells is recommended and the relative merits of this versus repeated limiting-dilution cloning are discussed.

Mesh:

Substances:

Year:  1988        PMID: 3343515     DOI: 10.1016/0022-1759(88)90017-8

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  9 in total

Review 1.  Use of Human Hybridoma Technology To Isolate Human Monoclonal Antibodies.

Authors:  Scott A Smith; James E Crowe
Journal:  Microbiol Spectr       Date:  2015-02

2.  Proteome alterations during clonal isolation of established human pancreatic cancer cell lines.

Authors:  P Bernhard; T Feilen; M Rogg; K Fröhlich; M Cosenza-Contreras; F Hause; C Schell; O Schilling
Journal:  Cell Mol Life Sci       Date:  2022-10-22       Impact factor: 9.207

3.  Assurance of monoclonality in one round of cloning through cell sorting for single cell deposition coupled with high resolution cell imaging.

Authors:  Krista Evans; Thomas Albanetti; Raghavan Venkat; Ronald Schoner; James Savery; Guillermo Miro-Quesada; Bhargavi Rajan; Christopher Groves
Journal:  Biotechnol Prog       Date:  2015-09-18

4.  A Microfluidic Single-Cell Cloning (SCC) Device for the Generation of Monoclonal Cells.

Authors:  Chuan-Feng Yeh; Ching-Hui Lin; Hao-Chen Chang; Chia-Yu Tang; Pei-Tzu Lai; Chia-Hsien Hsu
Journal:  Cells       Date:  2020-06-18       Impact factor: 6.600

Review 5.  Microfluidics applications for high-throughput single cell sequencing.

Authors:  Wen-Min Zhou; Yan-Yan Yan; Qiao-Ru Guo; Hong Ji; Hui Wang; Tian-Tian Xu; Bolat Makabel; Christian Pilarsky; Gen He; Xi-Yong Yu; Jian-Ye Zhang
Journal:  J Nanobiotechnology       Date:  2021-10-11       Impact factor: 10.435

Review 6.  Technologies for Single-Cell Isolation.

Authors:  Andre Gross; Jonas Schoendube; Stefan Zimmermann; Maximilian Steeb; Roland Zengerle; Peter Koltay
Journal:  Int J Mol Sci       Date:  2015-07-24       Impact factor: 5.923

7.  Advances in Mammalian cell line development technologies for recombinant protein production.

Authors:  Tingfeng Lai; Yuansheng Yang; Say Kong Ng
Journal:  Pharmaceuticals (Basel)       Date:  2013-04-26

8.  Novel millimeter-wave-based method for in situ cell isolation and other applications.

Authors:  Barney Boyce; Natalia Samsonova
Journal:  Sci Rep       Date:  2018-10-03       Impact factor: 4.379

9.  Characterization of newly established Pralatrexate-resistant cell lines and the mechanisms of resistance.

Authors:  Kana Oiwa; Naoko Hosono; Rie Nishi; Luigi Scotto; Owen A O'Connor; Takahiro Yamauchi
Journal:  BMC Cancer       Date:  2021-07-31       Impact factor: 4.430

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.